Abbott Laboratories (ABT) stock analysis
In our weekly check, Abbott Laboratories is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 16 pass, warnings: 8, red flags: 1.
About Abbott Laboratories
Abbott Laboratories is a Healthcare company (Medical Devices) based in the United States, listed on NYSE as ABT.
What our checks show for ABT
Red flags
- The net margin fell by 6.7 points over 5 years, to 9.7%: the company keeps less of each sale as profit.
Warning signs
- Revenue grew only 3.4% a year over the last 3 years.
- Earnings per share fell 11.8% a year over the last 3 years.
- Net profit fell 12.1% a year over the last 3 years.
- The net margin is only 9.7%: little room if costs rise.
- The dividend takes 92% of profit: little cushion if profit falls.
- The stock has fallen as much as 42% from a peak. Would you have held through that?
- The stock is still below its previous peak.
- Return on capital (ROCE) is only 7.9%.
Strengths
- The gross margin is 57% and has risen by 3.1 points: pricing power is holding.
- Operating cash flow is 1.88x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 47.7% a year over the next years.
- Analysts expect the net margin to improve by 10.1 points from today's 9.7%.
- Free cash flow is 14% of revenue: cash for dividends, buybacks or growth.
- A large company: market value $188 billion.
Next earnings report: 2027-01-28
Similar companies
MDT · SYK · BSX · EW · GEHC · DXCM
Questions
What grade does Abbott Laboratories (ABT) have?
In our weekly check, Abbott Laboratories is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 16 pass, warnings: 8, red flags: 1. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of ABT stock?
This week's biggest flags for Abbott Laboratories: Margins falling, Weak revenue growth, Weak EPS growth. In total 9 of 25 checks show a warning or a red flag.
What does Abbott Laboratories do?
Abbott Laboratories is a Healthcare company (Medical Devices) based in the United States, listed on NYSE as ABT.
When does Abbott Laboratories report earnings next?
The next earnings report is expected on 2027-01-28. We re-run the checks every week, so the grade can change after it.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis